Immunome (IMNM) Cash from Operations (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Immunome | 2.47 Bn | 1.89 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.28% |
| Dec 31, 2025 | -18.37% |
| Sep 30, 2025 | 18.00% |
| Jun 30, 2025 | 6.89% |
| Mar 31, 2025 | -26.14% |
| Dec 31, 2024 | -23.10% |
| Sep 30, 2024 | -46.03% |
| Jun 30, 2024 | -109.46% |
| Mar 31, 2024 | 36.02% |
| Dec 31, 2023 | -102.68% |
| Sep 30, 2023 | -51.98% |
| Jun 30, 2023 | -123.45% |
| Mar 31, 2023 | 461.71% |
| Dec 31, 2022 | 11.73% |
| Sep 30, 2022 | 6.07% |
| Jun 30, 2022 | -26.41% |
| Mar 31, 2022 | 6.30% |
| Dec 31, 2021 | -64.17% |
| Sep 30, 2021 | -10.80% |
| Jun 30, 2021 | -5.83% |
| Mar 31, 2021 | 41.69% |
| Dec 31, 2020 | -139.79% |
| Sep 30, 2020 | -70.81% |
| Jun 30, 2020 | 28.29% |
| Mar 31, 2020 | 19.97% |